Protein stability and aggregation in Parkinson's disease

Area of Science:

• Neurodegenerative diseases
• Cellular biology
• Neuropharmacology

Background:

• Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder, characterized by motor deficits.
• Clinical symptoms of PD appear late, after 70-80% of dopaminergic neurons are lost, complicating etiological research.
• The hallmark pathology of PD includes intracellular Lewy bodies and Lewy neurites, indicating impaired protein handling in neurons.

Purpose of the Study:

• To review the complex etiology of Parkinson's disease, encompassing genetic and environmental factors.
• To discuss the proposed mechanisms underlying sporadic PD, focusing on protein processing and mitochondrial dysfunction.
• To explore why dopaminergic neurons are particularly vulnerable in PD pathogenesis.

Main Methods:

• Review of existing literature on Parkinson's disease.
• Analysis of studies involving genetic models of rare hereditary PD forms.
• Examination of research on mitochondrial toxins that replicate PD's behavioral effects.

Main Results:

• The review proposes that in sporadic PD, interconnected protein processing deficits and mitochondrial abnormalities initiate age-related protein damage.
• These cellular stresses reduce the capacity to manage protein damage, leading to the formation of inclusions.
• This ultimately results in dopaminergic neuron toxicity and the clinical manifestation of Parkinson's disease.

Conclusions:

• Parkinson's disease etiology is multifactorial, involving genetic and environmental influences.
• Impaired protein processing and mitochondrial dysfunction are key contributors to the pathogenesis of sporadic PD.
• Understanding these mechanisms offers potential therapeutic targets for Parkinson's disease.